$ Value
$0
Shares
3,903
Price
$0
Filed
Aug 15
Insider
Name
van der Vaart Sandra D
Title
EVP, Chief Legal Officer
CIK
0001537208
Roles
Transaction Details
Transaction Date
2025-08-13
Code
M
Table
Derivative
Ownership
Direct
Equity Swap
No
Shares After
—
Footnotes
Amount includes 30.1294 shares acquired on June 30, 2025 under the Labcorp Holdings Inc. Amended and Restated 2016 Employee Stock Purchase Plan. | Employee stock option (right to buy) granted pursuant to the Labcorp Holdings Inc. Amended and Restated 2016 Omnibus Incentive Plan. | Represents amounts automatically adjusted based on the final adjustment ratio applied to equity awards in connection with the spin-off of Fortrea Holdings Inc. ("Fortrea") by Labcorp Holdings Inc. ("Labcorp"), calculated pursuant to the terms of the Employee Matters Agreement by and between Labcorp and Fortrea. | The option vested in three equal annual installments beginning on the date reflected in this column and is now fully exercisable.
Filing Info
van der Vaart Sandra D's History
| Date | Ticker | Type | Value |
|---|---|---|---|
| 2026-03-26 | LH | A | $0 |
| 2026-03-26 | LH | F | $731K |
| 2026-02-27 | LH | ▼ | $156K |
| 2026-02-11 | LH | M | — |
| 2026-02-11 | LH | F | $29K |
| 2026-02-11 | LH | M | $0 |
| 2026-02-09 | LH | F | $25K |
| 2026-02-07 | LH | M | — |
| 2026-02-07 | LH | M | $0 |
| 2026-02-06 | LH | M | — |
Other Insiders at LH (90d)
| Insider | Bought | Sold | Last |
|---|---|---|---|
|
GRAHAM ANITA Z
EVP, CHRO
|
— | — | 2026-03-26 |
| ANDERSON KERRII B | — | — | 2026-02-11 |
| NEUPERT PETER M | — | — | 2026-02-11 |
|
Schechter Adam H
President & CEO
|
— | $3.9M | 2026-03-26 |
|
Wilkinson Peter J
SVP, Chief Accounting Officer
|
— | $621K | 2026-03-27 |
| Kong Garheng | — | — | 2026-02-11 |
|
van der Vaart Sandra D
EVP, Corporate Affairs
|
— | $156K | 2026-03-26 |
| Parham Richelle P | — | — | 2026-02-11 |
| Rothman Paul | — | — | 2026-02-11 |
| Davis Jeffrey A. | — | — | 2026-02-11 |
|
Caveney Brian J
EVP, Pres of ED, CMO & CSO
|
— | $429K | 2026-03-26 |
| Wengel Kathryn E | — | — | 2026-02-11 |
|
Schroeder Mark S
EVP, Pres Diagnostics & COO
|
— | — | 2026-03-26 |
|
Summy Amy B.
EVP, Chief Marketing Officer
|
— | — | 2026-03-26 |
|
Wang Julia Aijun
Chief Financial Officer, EVP
|
— | — | 2026-02-11 |
| Kliphouse Kirsten Marie | — | — | 2026-02-11 |
|
Bailey Megan D.
EVP, Pres, Central Labs & Intl
|
— | — | 2026-03-26 |
|
Oyegunwa Akinbolade
EVP, CIO & CTO
|
— | — | 2026-03-26 |
| Bulto Carulla Victor | — | — | 2026-02-10 |
|
Kyle Kathryn W
EVP, Chief Legal Officer
|
— | — | 2026-03-26 |
|
Meltzer Jonathan C
EVP, Operations
|
— | $299K | 2026-03-27 |
|
Vaughn Bryan T
EVP, Diagnostics
|
— | — | 2026-03-26 |
| Sampson John H | — | — | 2026-02-10 |